Home Value Investing Aswath Damodaran – Divergence: The Changing Drug Business

Aswath Damodaran – Divergence: The Changing Drug Business

When you purchase through our sponsored links, we may earn a commission. By using this website you agree to our T&Cs.


Aswath Damodaran Divergence: The Changing Drug Business

Published on Nov 13, 2015

In this session, I look at how the prescription drug business is changing, particularly in the US, and the implications for R&D and investing at these companies.
Slides: http://www.stern.nyu.edu/~adamodar/pd…
Blog post: http://aswathdamodaran.blogspot.com/2…

Our Editorial Standards

At ValueWalk, we’re committed to providing accurate, research-backed information. Our editors go above and beyond to ensure our content is trustworthy and transparent.

Aswath Damodaran
Editor

Want Financial Guidance Sent Straight to You?

  • Pop your email in the box, and you'll receive bi-weekly emails from ValueWalk.
  • We never send spam — only the latest financial news and guides to help you take charge of your financial future.